SNDL Inc. (SNDL) Q2 2025 Earnings Call Transcript

SNDL Inc. reported its first-ever positive operating income and net earnings in Q2 2025, marking a significant financial milestone. Consolidated net revenue increased 7.3% year-over-year to C$245 million, with gross profit rising 16.2% to C$67.6 million, yielding a 27.6% gross margin. Adjusted operating income reached C$5.8 million, a 226% increase from the prior year, driven by the cannabis business outperforming the Canadian recreational market and liquor retail returning to growth. Despite negative free cash flow due to working capital investments for international expansion and seasonal payments, the company maintains a strong balance sheet with over C$200 million in unrestricted cash, positioning it for continued organic and inorganic growth, including the pending 1CM acquisition and ongoing efforts to consolidate US assets.

Analysis

SNDL Inc. has reached a pivotal financial milestone in its Q2 2025 results, reporting its first-ever positive operating income and net earnings. The company generated a consolidated net revenue of C$245 million, a 7.3% year-over-year increase, and an adjusted operating income of C$5.8 million, marking a C$10.4 million improvement from the prior year. This turnaround was driven by broad-based growth, with the Cannabis Operations segment delivering a standout 43% revenue increase to C$35.8 million, fueled by the Indiva acquisition and accelerating international sales of C$3.8 million. The Cannabis Retail segment also set a new revenue record of C$84.4 million, supported by an 8.2% rise in same-store sales, significantly outpacing the Canadian market. Notably, the Liquor Retail segment returned to growth with a 1% revenue increase, challenging narratives of secular decline in the sector, led by a 7.2% growth in its Wine and Beyond banner. Despite these strong operational results, free cash flow was negative C$7.9 million, attributed to working capital investments for international expansion and seasonal payments. The company maintains a robust balance sheet with over C$200 million in unrestricted cash and no debt, positioning it for strategic initiatives, including the pending 1CM acquisition and eventual consolidation of its U.S. assets. However, the timeline for realizing value from U.S. assets like Parallel and Skymint remains uncertain, pending the resolution of ongoing litigation which has been delayed in state courts.

Key Decisions for Investors

• Given the company's first-ever quarterly operating profit and strong growth across all segments, investors should assess whether this marks a sustainable inflection point justifying a re-evaluation of the stock's long-term value.
• Monitor free cash flow in the second half of 2025 to verify management's assertion that the current negative flow is temporary due to seasonal factors and growth investments, as a return to positive FCF would further validate the operational turnaround.
• The resolution of litigation surrounding U.S. assets represents a significant binary event; a favorable outcome could unlock substantial value, while continued delays or negative rulings remain a key risk and overhang on the stock.
• Track the execution of strategic growth pillars, specifically the ramp-up of higher-margin international cannabis sales in Q3 and the successful integration of the 1CM acquisition, as these are critical to maintaining profitability momentum.